All In MedTech

Device Trial Radar · NCT05893420

A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning

A Rapid Diagnostic of Risk in Hospitalized Patients With COVID-19, Sepsis, and Other High-Risk Conditions to Improve Outcomes and Critical Resource Allocation Using Machine Learning

Last checked: Nov 19, 2026Latest source record: Jul 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

30,000

Planned (sponsor's estimate)

Start

Dec 31, 2024

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
AgileMD, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Biomedical Advanced Research and Development Authority; University of Chicago; BayCare Health System; University of Wisconsin, Madison; Yale University
First posted
Jun 7, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In this study, the investigators will deploy a software-based clinical decision support tool (eCARTv5) into the electronic health record (EHR) workflow of multiple hospital wards. eCART's algorithm is designed to analyze real-time EHR data, such as vitals and laboratory results, to identify which patients are at increased risk for clinical deterioration. The algorithm specifically predicts imminent death or the need for intensive care unit (ICU) transfer. Within the eCART interface, clinical teams are then directed toward standardized guidance to determine next steps in care for elevated-risk patients. The investigators hypothesize that implementing such a tool will be associated with a decrease in ventilator utilization, length of stay, and mortality for high-risk hospitalized adults.

Conditions

  • Sepsis
  • Septicemia
  • Respiratory Failure
  • Hemodynamic Instability
  • COVID-19
  • Cardiac Arrest
  • Clinical Deterioration

Interventions

  • eCARTv5 clinical deterioration monitoringDevice

    eCART is a predictive analytic used for the identification of acute clinical deterioration built upon more than a decade of ongoing scientific research and chronicled in numerous peer-reviewed publications. eCART draws upon readily available patient data from the EHR, rapidly quantifies disease severity, and predicts the likelihood of critical illness onset.

  • Standard of care controlOther

    Standard of care is the health system's clinical best practices and workflows for identifying high-risk patients for clinical deterioration, including other tools already built into the electronic health record (EHR). Hospitals that do not implement eCARTv5 will be compared as a control against hospitals that do implement eCARTv5.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hospital mortality for elevated risk patientsTime frame: The outcome of hospital mortality for elevated risk patients will be tracked across 12 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Yale New Haven Health System

    New Haven, Connecticut

  • BayCare Health System

    Clearwater, Florida

  • University of Wisconsin Health

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.